Turkish adaptation and validation of the DSM-5-based premenstrual symptom screening tool.
This study adapted and validated the DSM-5-Based Premenstrual Symptom Screening Tool (DSM-5 PMS-ST) for Turkish populations. Existing Turkish screening instruments remain anchored to superseded DSM-IV criteria, and menstruation-related stigma may further impede symptom disclosure, underscoring the n…
Poor mood after oral contraceptive use is associated with increased vulnerability to peripartum depression, premenstrual dysphoric disorder, and higher genetic risk for depression.
This study tested whether adverse mood effect of the oral contraceptive pill (OCP) is associated with reproductive depressive episodes, including peripartum depression (PPD), premenstrual dysphoric disorder (PMDD), and perimenopausal depression. In a sample of 3,547 OCP users from the Australian Gen…
Reliability and Validity of the Chinese Version of the Premenstrual Symptoms Screening Tool.
To evaluate the reliability and validity of the Chinese version of the Premenstrual Symptoms Screening Tool (PSST) in a sample of Chinese female college students. A total of 1366 female college students completed the Chinese version of the PSST, the Patient Health Questionnaire (PHQ), and the Genera…
Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: An overview for clinicians.
To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle-related processes-particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)-into psychological assessment, formulation and treatment. Na…
Design, synthesis, and quantitative structure-activity modeling of indole-3-pyrimidine hydrazone derivatives as novel antifungal agents.
Fungicides remain the primary approach for preventing and controlling agricultural and forestry fungal diseases. However, the inevitable emergence of antifungal drug resistance in plant pathogenic fungi necessitates novel multi-target fungicides. A series of novel indole-3-pyrimidine hydrazones were…
Prevalence, Risk Factors, and Treatments for Suicidality in People Living with Premenstrual Dysphoric Disorder (PMDD): A Systematic Review.
In 2013, premenstrual dysphoric disorder (PMDD) was officially recognized as a psychiatric diagnosis. It is estimated to affect 1.3% to 5.8% of people who menstruate. Previous evidence has suggested an association between PMDD and suicidality. We set out to systematically review the most up-to-date…
Menstruation in adolescents with familial Mediterranean fever: attack trigger or dysmenorrhoea? A prospective cross-sectional study.
This study investigated the relationship between menstruation and familial Mediterranean fever (FMF) attacks in adolescents and whether menstrual symptoms indicate true FMF flares or primary dysmenorrhoea (PD) or premenstrual syndrome (PMS). This prospective cross-sectional study included 42 adolesc…
Increased Glymphatic System Activity and Hypothalamic Connectivity in Patients With Premenstrual Dysphoric Disorder.
Premenstrual dysphoric disorder (PMDD), which is an emotional disorder characterized by symptoms of irritability, depression, anxiety, and sleep disturbances during the luteal phase of the menstrual cycle. Advanced neuroimaging findings provided insights into the neurobiological underpinnings of PMD…